{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:51:40Z","timestamp":1773283900914,"version":"3.50.1"},"reference-count":21,"publisher":"Wiley","issue":"5","license":[{"start":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T00:00:00Z","timestamp":1484179200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["bjui-journals.onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["BJU International"],"published-print":{"date-parts":[[2017,5]]},"abstract":"<jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      To evaluate a multicentre series of robot\u2010assisted partial nephrectomy (\n                      <jats:styled-content style=\"fixed-case\">RAPN<\/jats:styled-content>\n                      ) performed for the treatment of large angiomyolipomas (\n                      <jats:styled-content style=\"fixed-case\">AML<\/jats:styled-content>\n                      s).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Patients and Methods<\/jats:title>\n                    <jats:p>\n                      Between 2005 and 2016, 40 patients with large or symptomatic\n                      <jats:styled-content style=\"fixed-case\">AML<\/jats:styled-content>\n                      s underwent\n                      <jats:styled-content style=\"fixed-case\">RAPN<\/jats:styled-content>\n                      at five academic centres in the\n                      <jats:styled-content style=\"fixed-case\">USA<\/jats:styled-content>\n                      . Patient demographics,\n                      <jats:styled-content style=\"fixed-case\">AML<\/jats:styled-content>\n                      characteristics, operative and postoperative clinical outcomes were recorded and analysed. Surgical outcomes were compared between patients who underwent selective arterial embolisation (\n                      <jats:styled-content style=\"fixed-case\">SAE<\/jats:styled-content>\n                      ) before\n                      <jats:styled-content style=\"fixed-case\">RAPN<\/jats:styled-content>\n                      and patients who did not undergo pre\u2010\n                      <jats:styled-content style=\"fixed-case\">RAPN SAE<\/jats:styled-content>\n                      .\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      The median (interquartile range [\n                      <jats:styled-content style=\"fixed-case\">IQR<\/jats:styled-content>\n                      ]) tumour diameter was 7.2 (5\u20138.5) cm, and the median (\n                      <jats:styled-content style=\"fixed-case\">IQR<\/jats:styled-content>\n                      ) nephrometry score was 9 (7\u201310). Six patients (15%) had a history of tuberous sclerosis and 11 (28%) had previously undergone\n                      <jats:styled-content style=\"fixed-case\">SAE<\/jats:styled-content>\n                      . The median (\n                      <jats:styled-content style=\"fixed-case\">IQR<\/jats:styled-content>\n                      ) operative time and warm ischaemia time was 207 (180\u2013231) and 22.5 (16\u201328) min, respectively. A non\u2010clamping technique was used in eight (20%) patients. The median (\n                      <jats:styled-content style=\"fixed-case\">IQR<\/jats:styled-content>\n                      ) estimated blood loss was 200 (100\u2013245)\n                      <jats:styled-content style=\"fixed-case\">mL<\/jats:styled-content>\n                      , and four patients (10%) received blood transfusion postoperatively. One intraoperative complication occurred (2.5%), and seven postoperative complications occurred in six patients (15%). During a median (\n                      <jats:styled-content style=\"fixed-case\">IQR<\/jats:styled-content>\n                      ) follow\u2010up of 8 (1\u201315) months, none of the patients developed\n                      <jats:styled-content style=\"fixed-case\">AML<\/jats:styled-content>\n                      \u2010related symptoms. The median estimated glomerular filtration rate preservation rate was 95%. There were no differences in operative or perioperative outcomes between patients who underwent\n                      <jats:styled-content style=\"fixed-case\">SAE<\/jats:styled-content>\n                      before\n                      <jats:styled-content style=\"fixed-case\">RAPN<\/jats:styled-content>\n                      and those who did not.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>\n                      Robot\u2010assisted partial nephrectomy appears to be a safe primary or secondary (post\u2010\n                      <jats:styled-content style=\"fixed-case\">SAE<\/jats:styled-content>\n                      ) treatment for large\n                      <jats:styled-content style=\"fixed-case\">AML<\/jats:styled-content>\n                      s, with a favourable perioperative morbidity profile and excellent functional preservation. Longer follow\u2010up is required to fully evaluate therapeutic efficacy.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/bju.13747","type":"journal-article","created":{"date-parts":[[2016,12,18]],"date-time":"2016-12-18T03:36:39Z","timestamp":1482032199000},"page":"755-760","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":15,"title":["Safety and early effectiveness of robot\u2010assisted partial nephrectomy for large angiomyolipomas"],"prefix":"10.1111","volume":"119","author":[{"given":"Shay","family":"Golan","sequence":"first","affiliation":[{"name":"Section of Urology University of Chicago Chicago IL USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott C.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Section of Urology University of Chicago Chicago IL USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0324-8795","authenticated-orcid":false,"given":"Matthew J.","family":"Maurice","sequence":"additional","affiliation":[{"name":"The Glickman Urological &amp; Kidney Institute Cleveland Clinic Cleveland OH USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jihad H.","family":"Kaouk","sequence":"additional","affiliation":[{"name":"The Glickman Urological &amp; Kidney Institute Cleveland Clinic Cleveland OH USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weil R.","family":"Lai","sequence":"additional","affiliation":[{"name":"Department of Urology Tulane University New Orleans LA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Benjamin R.","family":"Lee","sequence":"additional","affiliation":[{"name":"Department of Urology Tulane University New Orleans LA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven V.","family":"Kheyfets","sequence":"additional","affiliation":[{"name":"Department of Urology Indiana University Indianapolis IN USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chandru P.","family":"Sundaram","sequence":"additional","affiliation":[{"name":"Department of Urology Indiana University Indianapolis IN USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David B.","family":"Cahn","sequence":"additional","affiliation":[{"name":"Division of Urologic Oncology and Urology Fox Chase Cancer Center Philadelphia PA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert G.","family":"Uzzo","sequence":"additional","affiliation":[{"name":"Division of Urologic Oncology and Urology Fox Chase Cancer Center Philadelphia PA USA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arieh L.","family":"Shalhav","sequence":"additional","affiliation":[{"name":"Section of Urology University of Chicago Chicago IL USA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2017,1,12]]},"reference":[{"key":"e_1_2_8_2_1","first-page":"21","article-title":"Angiomyolipoma of kidney","volume":"15","author":"Eble JN","year":"1998","journal-title":"Semin Diagn Pathol"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1111\/bju.12604"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.2251011477"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1186\/s12894-015-0118-2"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-5347(17)35895-0"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2016.01.048"},{"key":"e_1_2_8_8_1","unstructured":"LjungbergB BensalahK BexAet al.European Association of Urology Guidelines on Renal Cell Carcinoma. Available at:https:\/\/uroweb.org\/guideline\/renal-cell-carcinoma\/. Accessed December 2016."},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2015.04.081"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2007.07.045"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1089\/end.2009.0330"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2009.05.035"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2009.03.041"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-150-9-200905050-00006"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1464-410X.2009.08649.x"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.urology.2008.07.049"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2015.07.126"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.juro.2007.03.038"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1245\/s10434-016-5411-0"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1089\/end.2015.0624"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1007\/s00345-012-0961-7"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1148\/radiol.11102476"}],"container-title":["BJU International"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fbju.13747","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/bju.13747","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,29]],"date-time":"2025-10-29T17:30:27Z","timestamp":1761759027000},"score":1,"resource":{"primary":{"URL":"https:\/\/bjui-journals.onlinelibrary.wiley.com\/doi\/10.1111\/bju.13747"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,1,12]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["10.1111\/bju.13747"],"URL":"https:\/\/doi.org\/10.1111\/bju.13747","archive":["Portico"],"relation":{},"ISSN":["1464-4096","1464-410X"],"issn-type":[{"value":"1464-4096","type":"print"},{"value":"1464-410X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1,12]]},"assertion":[{"value":"2017-01-12","order":3,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}